CATTF yields 30303.03% · PFE yields 6.20%● Live data
📍 CATTF pulled ahead of the other in Year 1
Combined, CATTF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CATTF + PFE for your $10,000?
CAT Strategic Metals Corporation engages in the acquisition and exploration of mineral properties in Canada. It primarily explores for uranium, gold, silver, and copper deposits. The company holds a 100% interest in the South Preston Uranium property covering approximately 29,395 hectares located in Saskatchewan, Canada; and the Gold Jackpot property comprising 64 unpatented lode claims that covers an area of 535 hectares located to the southeast of Jackpot, Nevada. It also holds interest in the Rimrock project that covers an area of 1,663 acres situated in Northwest of Elko, Nevada; and the Burntland mineral property covering approximately 1,200 hectares located in county of Restigouche, New Brunswick, Canada. The company was formerly known as Chimata Gold Corp. and changed its name to CAT Strategic Metals Corporation in February 2019. CAT Strategic Metals Corporation was incorporated in 2010 and is headquartered in Vancouver, Canada.
Full CATTF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.